Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Non-Interventional Study of K-ras Status Switch in K-ras Native Patients With Metastatic Colorectal Tumors Treated With FOLFIRI-Cetuximab as First-line Treatment

NCT01943786 is registered in ClinicalTrials.gov with Sofia Perea, Director Clinical Trials Unit. as lead sponsor.

NCT NCT01943786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01943786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Non-Interventional Study of K-ras Status Switch in K-ras Native Patients With Metastatic Colorectal Tumors Treated With FOLFIRI-Cetuximab as First-line Treatment
Lead sponsor
Sofia Perea, Director Clinical Trials Unit.
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2013
Completion date
December 31, 2015
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic